169 related articles for article (PubMed ID: 31782130)
1. Long-term remission of disseminated parathyroid cancer following immunotherapy.
Sarquis M; Marx SJ; Beckers A; Bradwell AR; Simonds WF; Bicalho MAC; Daly AF; Betea D; Friedman E; De Marco L
Endocrine; 2020 Jan; 67(1):204-208. PubMed ID: 31782130
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid cancer.
Sharretts JM; Kebebew E; Simonds WF
Semin Oncol; 2010 Dec; 37(6):580-90. PubMed ID: 21167377
[TBL] [Abstract][Full Text] [Related]
3. Concurrence of primary hyperparathyroidism and metastatic breast carcinoma affected a parathyroid gland.
Lee SH; Kim BH; Bae MJ; Yi YS; Kim WJ; Jeon YK; Kim SS; Kim YK; Kim IJ
J Clin Endocrinol Metab; 2013 Aug; 98(8):3127-30. PubMed ID: 23750035
[TBL] [Abstract][Full Text] [Related]
4. Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages.
Silva-Figueroa A; Villalobos P; Williams MD; Bassett RL; Clarke CN; Lee JE; Busaidy NL; Perrier ND
Surgery; 2018 Nov; 164(5):960-964. PubMed ID: 30033186
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid carcinoma: Challenges in diagnosis and treatment.
Betea D; Potorac I; Beckers A
Ann Endocrinol (Paris); 2015 May; 76(2):169-77. PubMed ID: 25910997
[TBL] [Abstract][Full Text] [Related]
6. Nonfunctional parathyroid carcinoma.
Giessler GA; Beech DJ
J Natl Med Assoc; 2001; 93(7-8):251-5. PubMed ID: 11491274
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid Carcinoma: Diagnosis and Clinical Implications.
Duan K; Mete Ö
Turk Patoloji Derg; 2015; 31 Suppl 1():80-97. PubMed ID: 26177319
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological correlates of hyperparathyroidism.
Duan K; Gomez Hernandez K; Mete O
J Clin Pathol; 2015 Oct; 68(10):771-87. PubMed ID: 26163537
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid carcinoma.
Goswamy J; Lei M; Simo R
Curr Opin Otolaryngol Head Neck Surg; 2016 Apr; 24(2):155-62. PubMed ID: 26771263
[TBL] [Abstract][Full Text] [Related]
10. The EIF4EBP3 translational repressor is a marker of CDC73 tumor suppressor haploinsufficiency in a parathyroid cancer syndrome.
Zhang JH; Seigneur EM; Pandey M; Loshakov A; Dagur PK; Connelly PS; Koo L; Panicker LM; Simonds WF
Cell Death Dis; 2012 Feb; 3(2):266. PubMed ID: 22297294
[TBL] [Abstract][Full Text] [Related]
11. The genomic profile of parathyroid carcinoma based on whole-genome sequencing.
Hu Y; Zhang X; Wang O; Bi Y; Xing X; Cui M; Wang M; Tao W; Liao Q; Zhao Y
Int J Cancer; 2020 Nov; 147(9):2446-2457. PubMed ID: 32574388
[TBL] [Abstract][Full Text] [Related]
12.
Storvall S; Ryhänen E; Heiskanen I; Vesterinen T; Bensch FV; Schildt J; Kytölä S; Karhu A; Arola J; Schalin-Jäntti C
J Endocr Soc; 2019 Nov; 3(11):2114-2122. PubMed ID: 31687638
[TBL] [Abstract][Full Text] [Related]
13. Case report: long-term remission of parathyroid cancer: possible relation to vitamin D and calcitriol therapy.
Palmieri-Sevier A; Palmieri GM; Baumgartner CJ; Britt LG
Am J Med Sci; 1993 Nov; 306(5):309-12. PubMed ID: 8238086
[TBL] [Abstract][Full Text] [Related]
14. Difficult management in parathyroid carcinoma with synchronous parathyroid hyperplasia.
Pagni F; Casella G; Bosisio FM; Costantini M; Fioretta G; Nicoletti G; Baldini V; DI Bella C
Minerva Endocrinol; 2017 Sep; 42(3):291-294. PubMed ID: 27677089
[No Abstract] [Full Text] [Related]
15. Parathyromatosis and parathyroid cancer.
Shen WT
Cancer Treat Res; 2010; 153():105-16. PubMed ID: 19957222
[No Abstract] [Full Text] [Related]
16. Parathyroid carcinoma.
Al-Kurd A; Mekel M; Mazeh H
Surg Oncol; 2014 Jun; 23(2):107-14. PubMed ID: 24742584
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of non-metastatic complication of malignant disease.
Stevenson GT
Lancet; 1999 Jan; 353(9150):340. PubMed ID: 9950433
[No Abstract] [Full Text] [Related]
18. Parathyroid carcinoma.
Rodgers SE; Perrier ND
Curr Opin Oncol; 2006 Jan; 18(1):16-22. PubMed ID: 16357559
[TBL] [Abstract][Full Text] [Related]
19. High-performance liquid chromatographic methods for the analysis of human parathyroid hormone in reference standards, parathyroid tissue and biological fluids.
Zanelli JM; Kent JC; Rafferty B; Nissenson RA; Nice EC; Capp MW; O'Hare MJ
J Chromatogr; 1983 Aug; 276(1):55-68. PubMed ID: 6672025
[TBL] [Abstract][Full Text] [Related]
20. A germline mutation of HRPT2/CDC73 (70 G>T) in an adolescent female with parathyroid carcinoma: first case report and a review of the literature.
Serrano-Gonzalez M; Shay S; Austin J; Maceri DR; Pitukcheewanont P
J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1005-12. PubMed ID: 27544721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
